comparemela.com
Home
Live Updates
Synlogic : Reports First Quarter 2023 Financial Results and Provides Business Update - Form 8-K : comparemela.com
Synlogic : Reports First Quarter 2023 Financial Results and Provides Business Update - Form 8-K
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
- Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023 -
... | May 11, 2023
Related Keywords
Cambridge
,
Cambridgeshire
,
United Kingdom
,
New York
,
United States
,
Aoife Brennan
,
Exchange Commission
,
Synlogic Inc
,
Society For Inherited Metabolic Disorders
,
Nasdaq
,
Drug Administration
,
European Medicines Agency
,
Synlogic Reports First Quarter
,
Provides Business Update
,
Rare Pediatric
,
Orphan Drug Designations
,
Synlogic President
,
Chief Executive
,
Synthetic Biotics
,
Recent Business Highlights
,
Orphan Drug Designation
,
Rare Pediatric Disease Designation
,
Inherited Metabolic Disorders
,
Synthetic Biotic
,
Industry Conference Participation
,
Jefferies Global Healthcare Conference
,
Ginkgo Bioworks
,
Private Securities Litigation Reform Act
,
Synlogic
,
Nc Stock Exchange
,
News
,
Information
,
Press Release
,
Reports
,
First
,
Quarter
,
023
,
Financial
,
Results
,
End
,
Rovides
,
Business
,
Phenylketonuria
,
Program
,
N
,
Track
,
Or
,
Hase
,
,
Trial
,
Initiation
,
Calf
,
F
,
023 Sybx Us87166l1008
,
comparemela.com © 2020. All Rights Reserved.